Clinical Trials
24 trialsNCT05812807 2026-06-05
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06498635 2026-06-03
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT05375617 2026-06-02
EPICkids
Columbia University
Recruiting
NCT05976763 2026-06-02
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT07613385 2026-05-29
Individualized AML Treatment
City of Hope Medical Center
Recruiting
NCT00949819 2026-05-26
ASCaP
Jonsson Comprehensive Cancer Center
Recruiting
NCT06974370 2026-05-26
ACTION-Brain
University of Vermont Medical Center
Phase 2 Recruiting
NCT06998342 2026-05-26
MOHSAHRTSS
University of Vermont Medical Center
Phase 2 Recruiting
NCT07023432 2026-05-22
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT03594630 2026-05-20
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07513389 2026-05-20
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Medical University of South Carolina
Phase 2 Recruiting
NCT06733350 2026-05-14
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Recruiting
NCT02609685 2026-05-07
PMCAS
Cedars-Sinai Medical Center
Phase NA Recruiting
NCT03180268 2026-05-07
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Phase 3 Recruiting
NCT06401330 2026-05-05
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Children's Oncology Group
Phase 3 Recruiting
NCT06647953 2026-05-05
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Children's Oncology Group
Phase 3 Recruiting
NCT03803553 2026-05-01
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Massachusetts General Hospital
Phase 3 Recruiting
NCT06792994 2026-04-30
CLL2000
German CLL Study Group
Recruiting
NCT07547163 2026-04-23
LGG PRO's
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Recruiting
NCT06378866 2026-04-20
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT07405476 2026-04-17
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Phase 2 Recruiting
NCT06539468 2026-04-14
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT05873608 2026-04-06
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
Phase NA Recruiting
NCT07270861 2026-03-24
Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study
Fudan University
Recruiting